Lessons in gene-environment interactions from the UK Biobank - clinical implications

I. Hall (Nottingham (Nottinghamshire), United Kingdom)

Source: International Congress 2018 – Gene-environment interactions in the omics era
Session: Gene-environment interactions in the omics era
Session type: Symposium
Number: 491

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Hall (Nottingham (Nottinghamshire), United Kingdom). Lessons in gene-environment interactions from the UK Biobank - clinical implications. International Congress 2018 – Gene-environment interactions in the omics era

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
DNA-based screening for CF: which protocol is best in a multiethnic Europe? Lessons from the UK experience
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Early origins: gene-environment interactions
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Cancer: an epidemiological perspective
Source: Eur Respir Monogr 2015; 67: 205-220
Year: 2015


Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007



How to design powerful international studies on gene-environment interaction
Source: Annual Congress 2008 - WS1 - Gene-environment interactions: challenges and pitfalls in study design, ethical issues and statistical analyses
Year: 2008



Better Medicines for Children - European regulation, European research networks, Funding opportunities
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020
Year: 2020



Update on GWAS in respiratory disease and relevance of gene-environment interactions
Source: Annual Congress 2013 –«Post GWAS» genetics of paediatric respiratory disease: current and future approaches
Year: 2013


ERS Clinical Research Collaborations: underpinning research excellence
Source: Eur Respir J, 52 (3) 1801534; 10.1183/13993003.01534-2018
Year: 2018



Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


Educational information events to enhance recruitment to clinical research trials
Source: International Congress 2015 – New developments in medical education, web and internet
Year: 2015


Implications of the exposome and its applicability in clinical and epidemiological studies
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016


European COPD Audit: how care is organised across Europe, methodological lessons learned - from a single country to a European study
Source: Annual Congress 2011 - Optimising healthcare for COPD across Europe
Year: 2011


Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


Clinical management of asthma in Asia-Pacific in 2000: the asthma insights and reality in Asia-Pacific (AIRIAP) study
Source: Eur Respir J 2001; 18: Suppl. 33, 441s
Year: 2001

Multi-centre research: The experience of a UK, Danish and Dutch qualitative study exploring the meaning of COPD and its exacerbations to patients
Source: Eur Respir J 2003; 22: Suppl. 45, 66s
Year: 2003